{"id":5019,"date":"2015-11-05T17:22:03","date_gmt":"2015-11-05T22:22:03","guid":{"rendered":"https:\/\/fomatmedical.com\/?p=5019"},"modified":"2026-04-27T14:27:13","modified_gmt":"2026-04-27T21:27:13","slug":"adolescent-substance-use-sbirt","status":"publish","type":"post","link":"https:\/\/fomatmedical.com\/es\/blogs-updates\/adolescent-substance-use-sbirt\/","title":{"rendered":"Una breve capacitaci\u00f3n aumenta el uso de intervenciones por abuso de sustancias y salud mental por parte de los pediatras"},"content":{"rendered":"

Adolescent Substance Use: 3 Alarming Findings From a Landmark SBIRT Training Study<\/strong><\/h2>\n

Adolescent substance use is one of the most pressing public health challenges in pediatric medicine. Underage drinking and drug use frequently coexist with mental health problems and carry serious long term consequences \u2014 from injuries and academic failure to lasting brain changes and dependency. Yet despite the scale of the problem, most pediatric primary care settings have historically had little infrastructure to address it.<\/p>\n

A new study funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, offers important evidence that brief, practical interventions can meaningfully change that. The findings were published in JAMA Pediatrics and have direct implications for how pediatric practices across the United States approach adolescent substance use screening and intervention.<\/p>\n

What Is SBIRT and Why Does It Matter for Adolescent Substance Use?<\/strong><\/h3>\n

SBIRT stands for Screening, Brief Intervention, and Referral to Treatment. It is a structured clinical approach designed to identify patients at risk for adolescent substance use and mental health problems, provide a brief counseling intervention at the point of care, and refer those who need more intensive support to appropriate treatment.<\/p>\n

Research has shown that primary care physicians who use SBIRT with adult patients can reduce heavy drinking, its harmful consequences, and associated healthcare costs. Mounting evidence now supports SBIRT as an effective tool for pediatricians to address adolescent substance use before problems escalate. However, two major barriers have limited widespread adoption: a lack of training and time constraints during clinical visits.<\/p>\n

The study, led by Stacy Sterling, Dr.P.H.(c.), M.S.W. at Kaiser Permanente Northern California, was designed to test practical approaches to overcoming both of those barriers simultaneously.<\/p>\n

Study Design: Nearly 50 Pediatricians and 1,900 Adolescents<\/strong><\/h3>\n

The two year trial enrolled nearly 50 pediatricians and approximately 1,900 adolescents at a large general pediatric care clinic. Participants were divided into three groups to compare different models for addressing adolescent substance use in primary care.<\/p>\n

The first group, called the pediatrician only group, received three 60 minute SBIRT training sessions and was expected to conduct full assessments and brief interventions independently.<\/p>\n

The second group received one 60 minute SBIRT training session and worked alongside embedded clinical psychologists who were placed directly within the practice to conduct interventions for patients identified at risk for adolescent substance use.<\/p>\n

The third group served as the usual care control. These pediatricians had access to the same clinical guidelines but received no SBIRT training and had no embedded behavioral health clinicians on their teams.<\/p>\n

3 Alarming Findings About Adolescent Substance Use Interventions<\/strong><\/h2>\n

Finding 1: Brief SBIRT Training Made Pediatricians 10 Times More Likely to Intervene<\/strong><\/h4>\n

The most striking finding in this adolescent substance use study was the magnitude of the improvement produced by even basic SBIRT training. Pediatricians in the training only group were approximately 10 times more likely to conduct brief interventions with at risk patients compared to those in the usual care group \u2014 16 percent versus just 1.5 percent.<\/p>\n

This means that without any training, the vast majority of pediatricians in usual care settings are missing nearly every opportunity to address adolescent substance use during clinical visits. Three hours of structured training changed that outcome dramatically.<\/p>\n

Finding 2: Embedding Behavioral Health Clinicians Produced the Highest Intervention Rates<\/strong><\/h4>\n

When trained pediatricians worked alongside embedded clinical psychologists, the brief intervention rate rose to 24.5 percent \u2014 higher than either the training only group or the usual care group. This model divided responsibilities between physicians and behavioral health specialists, allowing each to focus on what they are best equipped to do.<\/p>\n

This approach addresses the time constraint barrier that frequently prevents pediatricians from fully engaging with adolescent substance use concerns during standard appointments. Principal investigator Constance Weisner, Dr.P.H., M.S.W., noted that embedding non physician clinicians in primary care could be a cost effective alternative for providing these services at scale.<\/p>\n

Finding 3: Even With Training, Overall Attention to Adolescent Substance Use Remains Low<\/strong><\/h4>\n

Despite the significant improvements observed in both intervention groups, the study found that overall pediatrician attention to behavioral health and adolescent substance use concerns remained low in absolute terms. Even the best performing group intervened with fewer than 1 in 4 at risk patients.<\/p>\n

This finding underscores how much room remains for systemic improvement in how primary care addresses adolescent substance use. Training and embedded behavioral health support are effective tools, but broader structural changes in pediatric practice models will be needed to close the gap.<\/p>\n

What This Research Means for Clinical Practice<\/strong><\/h2>\n

NIAAA Director George F. Koob, Ph.D., noted that this research provides valuable new information about strategies that could improve SBIRT implementation in everyday pediatric practice settings \u2014 moving the needle from what is theoretically recommended to what is practically achievable.<\/p>\n

Future analyses from the same study are expected to examine patient outcomes and the cost effectiveness of both SBIRT approaches, which will be important for health systems considering how to allocate resources to address adolescent substance use at scale.<\/p>\n

For further reading on adolescent substance use research and active clinical studies, visit the National Institute on Alcohol Abuse and Alcoholism<\/a> and ClinicalTrials.gov<\/a>.<\/p>\n

Participate in Clinical Research With FOMAT\u00a0<\/strong><\/h2>\n

At FOMAT Medical, we support Phase I through Phase IV clinical studies across multiple therapeutic areas throughout the United States. Research addressing adolescent substance use, behavioral health, and mental health represents an area of significant unmet need in our patient communities.<\/p>\n

If you or someone you know may be interested in joining an active clinical study, explore our currently available trials.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Consumo de sustancias en adolescentes: tres hallazgos alarmantes de un estudio pionero sobre la capacitaci\u00f3n en SBIRT El consumo de sustancias en adolescentes es uno de los retos de salud p\u00fablica m\u00e1s acuciantes en la medicina pedi\u00e1trica. El consumo de alcohol y drogas entre menores de edad suele ir de la mano de problemas de salud mental y conlleva graves\u2026<\/p>","protected":false},"author":3,"featured_media":93150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[968],"tags":[],"class_list":["post-5019","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs-updates"],"acf":[],"_links":{"self":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/5019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/comments?post=5019"}],"version-history":[{"count":0,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/posts\/5019\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media\/93150"}],"wp:attachment":[{"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/media?parent=5019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/categories?post=5019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fomatmedical.com\/es\/wp-json\/wp\/v2\/tags?post=5019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}